An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study-Reference-Cited by-同舟云学术

An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study

Published:2011-12-02 Issue:6 Volume:27 Page:2303-2311
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Galle J.-C.,Claes K.,Kiss I.,Winearls C. G.,Herlitz H.,Guerin A.,Di Giulio S.,Suranyi M. G.,Bridges I.,Addison J.,Farouk M.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/6/2303/6907134/gfr677.pdf

Reference32 articles.

1. Darbepoetin Alfa Effectively Treats Anemia in Patients with Chronic Kidney Disease with de novo Every-Other-Week Administration

2. Treatment of Anemia with Darbepoetin Alfa Administered de novo Once Every Other Week in Chronic Kidney Disease

3. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

4. Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open-label, Australian study

5. Less frequent dosing of erythropoiesis stimulating agents in patients undergoing dialysis: a European multicentre cost study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conversion from Aranesp® to NESP ® in dialysis patients—Exploration of dosing strategies and the feasibility of extending the dosing interval;Nephrology;2021-04-20

2. Management of Anemia in Chronic Kidney Disease;Chronic Renal Disease;2020

3. Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study;Nephrology Dialysis Transplantation;2016-04-15

4. Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients;Therapeutic Apheresis and Dialysis;2015-05-05

5. Management of Anemia in Chronic Kidney Disease;Chronic Renal Disease;2015